nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—ABCB1—ovarian cancer	0.499	1	CbGaD
Acebutolol—ABCB1—Topotecan—ovarian cancer	0.0711	0.267	CbGbCtD
Acebutolol—ABCB1—Vinorelbine—ovarian cancer	0.0501	0.188	CbGbCtD
Acebutolol—CYP2D6—Vinorelbine—ovarian cancer	0.0472	0.178	CbGbCtD
Acebutolol—ABCB1—Paclitaxel—ovarian cancer	0.0352	0.132	CbGbCtD
Acebutolol—ABCB1—Docetaxel—ovarian cancer	0.0254	0.0957	CbGbCtD
Acebutolol—ABCB1—Doxorubicin—ovarian cancer	0.019	0.0713	CbGbCtD
Acebutolol—CYP2D6—Doxorubicin—ovarian cancer	0.0179	0.0672	CbGbCtD
Acebutolol—Mood swings—Epirubicin—ovarian cancer	0.000331	0.00141	CcSEcCtD
Acebutolol—Vertigo—Paclitaxel—ovarian cancer	0.000331	0.00141	CcSEcCtD
Acebutolol—Syncope—Paclitaxel—ovarian cancer	0.00033	0.00141	CcSEcCtD
Acebutolol—Lethargy—Doxorubicin—ovarian cancer	0.00033	0.00141	CcSEcCtD
Acebutolol—Rash—Topotecan—ovarian cancer	0.000329	0.0014	CcSEcCtD
Acebutolol—Dermatitis—Topotecan—ovarian cancer	0.000329	0.0014	CcSEcCtD
Acebutolol—Headache—Topotecan—ovarian cancer	0.000327	0.0014	CcSEcCtD
Acebutolol—Palpitations—Paclitaxel—ovarian cancer	0.000326	0.00139	CcSEcCtD
Acebutolol—Angiopathy—Docetaxel—ovarian cancer	0.000325	0.00139	CcSEcCtD
Acebutolol—Vomiting—Melphalan—ovarian cancer	0.000325	0.00139	CcSEcCtD
Acebutolol—Loss of consciousness—Paclitaxel—ovarian cancer	0.000324	0.00138	CcSEcCtD
Acebutolol—Pain in extremity—Doxorubicin—ovarian cancer	0.000324	0.00138	CcSEcCtD
Acebutolol—Mediastinal disorder—Docetaxel—ovarian cancer	0.000323	0.00138	CcSEcCtD
Acebutolol—Rash—Melphalan—ovarian cancer	0.000323	0.00138	CcSEcCtD
Acebutolol—Dermatitis—Melphalan—ovarian cancer	0.000322	0.00137	CcSEcCtD
Acebutolol—Chills—Docetaxel—ovarian cancer	0.000322	0.00137	CcSEcCtD
Acebutolol—Cough—Paclitaxel—ovarian cancer	0.000321	0.00137	CcSEcCtD
Acebutolol—Asthenia—Vinorelbine—ovarian cancer	0.000321	0.00137	CcSEcCtD
Acebutolol—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000319	0.00136	CcSEcCtD
Acebutolol—Affect lability—Doxorubicin—ovarian cancer	0.000318	0.00136	CcSEcCtD
Acebutolol—Alopecia—Docetaxel—ovarian cancer	0.000317	0.00135	CcSEcCtD
Acebutolol—Pruritus—Vinorelbine—ovarian cancer	0.000316	0.00135	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000315	0.00134	CcSEcCtD
Acebutolol—Chest pain—Paclitaxel—ovarian cancer	0.000314	0.00134	CcSEcCtD
Acebutolol—Myalgia—Paclitaxel—ovarian cancer	0.000314	0.00134	CcSEcCtD
Acebutolol—Arthralgia—Paclitaxel—ovarian cancer	0.000314	0.00134	CcSEcCtD
Acebutolol—Anxiety—Paclitaxel—ovarian cancer	0.000313	0.00133	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000311	0.00133	CcSEcCtD
Acebutolol—Nausea—Topotecan—ovarian cancer	0.00031	0.00132	CcSEcCtD
Acebutolol—Discomfort—Paclitaxel—ovarian cancer	0.00031	0.00132	CcSEcCtD
Acebutolol—Mood swings—Doxorubicin—ovarian cancer	0.000307	0.00131	CcSEcCtD
Acebutolol—Diarrhoea—Vinorelbine—ovarian cancer	0.000306	0.0013	CcSEcCtD
Acebutolol—Nausea—Melphalan—ovarian cancer	0.000304	0.0013	CcSEcCtD
Acebutolol—Confusional state—Paclitaxel—ovarian cancer	0.000303	0.00129	CcSEcCtD
Acebutolol—Back pain—Docetaxel—ovarian cancer	0.000302	0.00129	CcSEcCtD
Acebutolol—Oedema—Paclitaxel—ovarian cancer	0.000301	0.00128	CcSEcCtD
Acebutolol—Shock—Paclitaxel—ovarian cancer	0.000296	0.00126	CcSEcCtD
Acebutolol—Dizziness—Vinorelbine—ovarian cancer	0.000296	0.00126	CcSEcCtD
Acebutolol—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000296	0.00126	CcSEcCtD
Acebutolol—Nervous system disorder—Paclitaxel—ovarian cancer	0.000295	0.00126	CcSEcCtD
Acebutolol—Skin disorder—Paclitaxel—ovarian cancer	0.000292	0.00124	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000291	0.00124	CcSEcCtD
Acebutolol—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000291	0.00124	CcSEcCtD
Acebutolol—Anorexia—Paclitaxel—ovarian cancer	0.000287	0.00122	CcSEcCtD
Acebutolol—Vomiting—Vinorelbine—ovarian cancer	0.000284	0.00121	CcSEcCtD
Acebutolol—Dysuria—Epirubicin—ovarian cancer	0.000283	0.0012	CcSEcCtD
Acebutolol—Rash—Vinorelbine—ovarian cancer	0.000282	0.0012	CcSEcCtD
Acebutolol—Dermatitis—Vinorelbine—ovarian cancer	0.000282	0.0012	CcSEcCtD
Acebutolol—Hypotension—Paclitaxel—ovarian cancer	0.000281	0.0012	CcSEcCtD
Acebutolol—Headache—Vinorelbine—ovarian cancer	0.00028	0.00119	CcSEcCtD
Acebutolol—Syncope—Docetaxel—ovarian cancer	0.00028	0.00119	CcSEcCtD
Acebutolol—Palpitations—Docetaxel—ovarian cancer	0.000276	0.00118	CcSEcCtD
Acebutolol—Weight increased—Epirubicin—ovarian cancer	0.000275	0.00117	CcSEcCtD
Acebutolol—Loss of consciousness—Docetaxel—ovarian cancer	0.000274	0.00117	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000274	0.00117	CcSEcCtD
Acebutolol—Cough—Docetaxel—ovarian cancer	0.000272	0.00116	CcSEcCtD
Acebutolol—Insomnia—Paclitaxel—ovarian cancer	0.000272	0.00116	CcSEcCtD
Acebutolol—Pneumonia—Epirubicin—ovarian cancer	0.000271	0.00116	CcSEcCtD
Acebutolol—Paraesthesia—Paclitaxel—ovarian cancer	0.00027	0.00115	CcSEcCtD
Acebutolol—Drowsiness—Epirubicin—ovarian cancer	0.000269	0.00115	CcSEcCtD
Acebutolol—Dyspnoea—Paclitaxel—ovarian cancer	0.000268	0.00114	CcSEcCtD
Acebutolol—Somnolence—Paclitaxel—ovarian cancer	0.000267	0.00114	CcSEcCtD
Acebutolol—Arthralgia—Docetaxel—ovarian cancer	0.000266	0.00113	CcSEcCtD
Acebutolol—Chest pain—Docetaxel—ovarian cancer	0.000266	0.00113	CcSEcCtD
Acebutolol—Myalgia—Docetaxel—ovarian cancer	0.000266	0.00113	CcSEcCtD
Acebutolol—Nausea—Vinorelbine—ovarian cancer	0.000265	0.00113	CcSEcCtD
Acebutolol—Dyspepsia—Paclitaxel—ovarian cancer	0.000265	0.00113	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000264	0.00113	CcSEcCtD
Acebutolol—Conjunctivitis—Epirubicin—ovarian cancer	0.000262	0.00112	CcSEcCtD
Acebutolol—Dysuria—Doxorubicin—ovarian cancer	0.000262	0.00111	CcSEcCtD
Acebutolol—Decreased appetite—Paclitaxel—ovarian cancer	0.000261	0.00111	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00026	0.00111	CcSEcCtD
Acebutolol—Fatigue—Paclitaxel—ovarian cancer	0.000259	0.0011	CcSEcCtD
Acebutolol—Sweating—Epirubicin—ovarian cancer	0.000258	0.0011	CcSEcCtD
Acebutolol—Pain—Paclitaxel—ovarian cancer	0.000257	0.0011	CcSEcCtD
Acebutolol—Constipation—Paclitaxel—ovarian cancer	0.000257	0.0011	CcSEcCtD
Acebutolol—Confusional state—Docetaxel—ovarian cancer	0.000257	0.0011	CcSEcCtD
Acebutolol—Oedema—Docetaxel—ovarian cancer	0.000255	0.00109	CcSEcCtD
Acebutolol—Weight increased—Doxorubicin—ovarian cancer	0.000255	0.00108	CcSEcCtD
Acebutolol—Agranulocytosis—Epirubicin—ovarian cancer	0.000251	0.00107	CcSEcCtD
Acebutolol—Pneumonia—Doxorubicin—ovarian cancer	0.000251	0.00107	CcSEcCtD
Acebutolol—Shock—Docetaxel—ovarian cancer	0.000251	0.00107	CcSEcCtD
Acebutolol—Nervous system disorder—Docetaxel—ovarian cancer	0.00025	0.00107	CcSEcCtD
Acebutolol—Drowsiness—Doxorubicin—ovarian cancer	0.000249	0.00106	CcSEcCtD
Acebutolol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000248	0.00106	CcSEcCtD
Acebutolol—Skin disorder—Docetaxel—ovarian cancer	0.000248	0.00106	CcSEcCtD
Acebutolol—Bradycardia—Epirubicin—ovarian cancer	0.000246	0.00105	CcSEcCtD
Acebutolol—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000246	0.00105	CcSEcCtD
Acebutolol—Anorexia—Docetaxel—ovarian cancer	0.000243	0.00104	CcSEcCtD
Acebutolol—Rhinitis—Epirubicin—ovarian cancer	0.000243	0.00103	CcSEcCtD
Acebutolol—Conjunctivitis—Doxorubicin—ovarian cancer	0.000242	0.00103	CcSEcCtD
Acebutolol—Hypoaesthesia—Epirubicin—ovarian cancer	0.000241	0.00103	CcSEcCtD
Acebutolol—Pharyngitis—Epirubicin—ovarian cancer	0.00024	0.00102	CcSEcCtD
Acebutolol—Sweating—Doxorubicin—ovarian cancer	0.000239	0.00102	CcSEcCtD
Acebutolol—Urticaria—Paclitaxel—ovarian cancer	0.000239	0.00102	CcSEcCtD
Acebutolol—Hypotension—Docetaxel—ovarian cancer	0.000238	0.00102	CcSEcCtD
Acebutolol—Connective tissue disorder—Epirubicin—ovarian cancer	0.000238	0.00101	CcSEcCtD
Acebutolol—Body temperature increased—Paclitaxel—ovarian cancer	0.000238	0.00101	CcSEcCtD
Acebutolol—Abdominal pain—Paclitaxel—ovarian cancer	0.000238	0.00101	CcSEcCtD
Acebutolol—Visual impairment—Epirubicin—ovarian cancer	0.000233	0.000994	CcSEcCtD
Acebutolol—Agranulocytosis—Doxorubicin—ovarian cancer	0.000233	0.000992	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000232	0.00099	CcSEcCtD
Acebutolol—Insomnia—Docetaxel—ovarian cancer	0.00023	0.000982	CcSEcCtD
Acebutolol—Paraesthesia—Docetaxel—ovarian cancer	0.000229	0.000975	CcSEcCtD
Acebutolol—Bradycardia—Doxorubicin—ovarian cancer	0.000228	0.000971	CcSEcCtD
Acebutolol—Dyspnoea—Docetaxel—ovarian cancer	0.000227	0.000968	CcSEcCtD
Acebutolol—Somnolence—Docetaxel—ovarian cancer	0.000227	0.000966	CcSEcCtD
Acebutolol—Tinnitus—Epirubicin—ovarian cancer	0.000226	0.000962	CcSEcCtD
Acebutolol—Flushing—Epirubicin—ovarian cancer	0.000225	0.000957	CcSEcCtD
Acebutolol—Rhinitis—Doxorubicin—ovarian cancer	0.000224	0.000957	CcSEcCtD
Acebutolol—Dyspepsia—Docetaxel—ovarian cancer	0.000224	0.000956	CcSEcCtD
Acebutolol—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000223	0.000949	CcSEcCtD
Acebutolol—Pharyngitis—Doxorubicin—ovarian cancer	0.000222	0.000947	CcSEcCtD
Acebutolol—Decreased appetite—Docetaxel—ovarian cancer	0.000222	0.000944	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00022	0.000938	CcSEcCtD
Acebutolol—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00022	0.000938	CcSEcCtD
Acebutolol—Fatigue—Docetaxel—ovarian cancer	0.00022	0.000937	CcSEcCtD
Acebutolol—Angiopathy—Epirubicin—ovarian cancer	0.000219	0.000936	CcSEcCtD
Acebutolol—Mediastinal disorder—Epirubicin—ovarian cancer	0.000218	0.000929	CcSEcCtD
Acebutolol—Constipation—Docetaxel—ovarian cancer	0.000218	0.000929	CcSEcCtD
Acebutolol—Pain—Docetaxel—ovarian cancer	0.000218	0.000929	CcSEcCtD
Acebutolol—Chills—Epirubicin—ovarian cancer	0.000217	0.000925	CcSEcCtD
Acebutolol—Visual impairment—Doxorubicin—ovarian cancer	0.000216	0.00092	CcSEcCtD
Acebutolol—Asthenia—Paclitaxel—ovarian cancer	0.000216	0.000919	CcSEcCtD
Acebutolol—Alopecia—Epirubicin—ovarian cancer	0.000214	0.000911	CcSEcCtD
Acebutolol—Pruritus—Paclitaxel—ovarian cancer	0.000213	0.000907	CcSEcCtD
Acebutolol—Feeling abnormal—Docetaxel—ovarian cancer	0.00021	0.000895	CcSEcCtD
Acebutolol—Tinnitus—Doxorubicin—ovarian cancer	0.000209	0.00089	CcSEcCtD
Acebutolol—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000208	0.000888	CcSEcCtD
Acebutolol—Flushing—Doxorubicin—ovarian cancer	0.000208	0.000886	CcSEcCtD
Acebutolol—Flatulence—Epirubicin—ovarian cancer	0.000208	0.000885	CcSEcCtD
Acebutolol—Diarrhoea—Paclitaxel—ovarian cancer	0.000206	0.000877	CcSEcCtD
Acebutolol—Back pain—Epirubicin—ovarian cancer	0.000204	0.000868	CcSEcCtD
Acebutolol—Angiopathy—Doxorubicin—ovarian cancer	0.000203	0.000866	CcSEcCtD
Acebutolol—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000202	0.00086	CcSEcCtD
Acebutolol—Body temperature increased—Docetaxel—ovarian cancer	0.000201	0.000859	CcSEcCtD
Acebutolol—Abdominal pain—Docetaxel—ovarian cancer	0.000201	0.000859	CcSEcCtD
Acebutolol—Chills—Doxorubicin—ovarian cancer	0.000201	0.000856	CcSEcCtD
Acebutolol—Dizziness—Paclitaxel—ovarian cancer	0.000199	0.000847	CcSEcCtD
Acebutolol—Vision blurred—Epirubicin—ovarian cancer	0.000198	0.000846	CcSEcCtD
Acebutolol—Alopecia—Doxorubicin—ovarian cancer	0.000198	0.000843	CcSEcCtD
Acebutolol—Ill-defined disorder—Epirubicin—ovarian cancer	0.000195	0.000833	CcSEcCtD
Acebutolol—Flatulence—Doxorubicin—ovarian cancer	0.000192	0.000819	CcSEcCtD
Acebutolol—Vomiting—Paclitaxel—ovarian cancer	0.000191	0.000815	CcSEcCtD
Acebutolol—Malaise—Epirubicin—ovarian cancer	0.00019	0.00081	CcSEcCtD
Acebutolol—Rash—Paclitaxel—ovarian cancer	0.00019	0.000808	CcSEcCtD
Acebutolol—Dermatitis—Paclitaxel—ovarian cancer	0.000189	0.000807	CcSEcCtD
Acebutolol—Vertigo—Epirubicin—ovarian cancer	0.000189	0.000807	CcSEcCtD
Acebutolol—Syncope—Epirubicin—ovarian cancer	0.000189	0.000805	CcSEcCtD
Acebutolol—Back pain—Doxorubicin—ovarian cancer	0.000188	0.000803	CcSEcCtD
Acebutolol—Headache—Paclitaxel—ovarian cancer	0.000188	0.000803	CcSEcCtD
Acebutolol—Palpitations—Epirubicin—ovarian cancer	0.000186	0.000793	CcSEcCtD
Acebutolol—Loss of consciousness—Epirubicin—ovarian cancer	0.000185	0.000789	CcSEcCtD
Acebutolol—Cough—Epirubicin—ovarian cancer	0.000184	0.000783	CcSEcCtD
Acebutolol—Vision blurred—Doxorubicin—ovarian cancer	0.000184	0.000783	CcSEcCtD
Acebutolol—Asthenia—Docetaxel—ovarian cancer	0.000183	0.000779	CcSEcCtD
Acebutolol—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000181	0.000771	CcSEcCtD
Acebutolol—Pruritus—Docetaxel—ovarian cancer	0.00018	0.000769	CcSEcCtD
Acebutolol—Arthralgia—Epirubicin—ovarian cancer	0.000179	0.000764	CcSEcCtD
Acebutolol—Chest pain—Epirubicin—ovarian cancer	0.000179	0.000764	CcSEcCtD
Acebutolol—Myalgia—Epirubicin—ovarian cancer	0.000179	0.000764	CcSEcCtD
Acebutolol—Anxiety—Epirubicin—ovarian cancer	0.000179	0.000762	CcSEcCtD
Acebutolol—Nausea—Paclitaxel—ovarian cancer	0.000179	0.000761	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000178	0.000759	CcSEcCtD
Acebutolol—Discomfort—Epirubicin—ovarian cancer	0.000177	0.000755	CcSEcCtD
Acebutolol—Malaise—Doxorubicin—ovarian cancer	0.000176	0.000749	CcSEcCtD
Acebutolol—Vertigo—Doxorubicin—ovarian cancer	0.000175	0.000746	CcSEcCtD
Acebutolol—Syncope—Doxorubicin—ovarian cancer	0.000175	0.000745	CcSEcCtD
Acebutolol—Diarrhoea—Docetaxel—ovarian cancer	0.000174	0.000743	CcSEcCtD
Acebutolol—Confusional state—Epirubicin—ovarian cancer	0.000173	0.000739	CcSEcCtD
Acebutolol—Palpitations—Doxorubicin—ovarian cancer	0.000172	0.000734	CcSEcCtD
Acebutolol—Oedema—Epirubicin—ovarian cancer	0.000172	0.000733	CcSEcCtD
Acebutolol—Loss of consciousness—Doxorubicin—ovarian cancer	0.000171	0.00073	CcSEcCtD
Acebutolol—Cough—Doxorubicin—ovarian cancer	0.00017	0.000725	CcSEcCtD
Acebutolol—Shock—Epirubicin—ovarian cancer	0.000169	0.000721	CcSEcCtD
Acebutolol—Nervous system disorder—Epirubicin—ovarian cancer	0.000169	0.000719	CcSEcCtD
Acebutolol—Dizziness—Docetaxel—ovarian cancer	0.000169	0.000718	CcSEcCtD
Acebutolol—Skin disorder—Epirubicin—ovarian cancer	0.000167	0.000712	CcSEcCtD
Acebutolol—Hyperhidrosis—Epirubicin—ovarian cancer	0.000166	0.000708	CcSEcCtD
Acebutolol—Chest pain—Doxorubicin—ovarian cancer	0.000166	0.000707	CcSEcCtD
Acebutolol—Arthralgia—Doxorubicin—ovarian cancer	0.000166	0.000707	CcSEcCtD
Acebutolol—Myalgia—Doxorubicin—ovarian cancer	0.000166	0.000707	CcSEcCtD
Acebutolol—Anxiety—Doxorubicin—ovarian cancer	0.000165	0.000705	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000165	0.000702	CcSEcCtD
Acebutolol—Discomfort—Doxorubicin—ovarian cancer	0.000164	0.000699	CcSEcCtD
Acebutolol—Anorexia—Epirubicin—ovarian cancer	0.000164	0.000698	CcSEcCtD
Acebutolol—Vomiting—Docetaxel—ovarian cancer	0.000162	0.000691	CcSEcCtD
Acebutolol—Rash—Docetaxel—ovarian cancer	0.000161	0.000685	CcSEcCtD
Acebutolol—Hypotension—Epirubicin—ovarian cancer	0.000161	0.000685	CcSEcCtD
Acebutolol—Dermatitis—Docetaxel—ovarian cancer	0.000161	0.000684	CcSEcCtD
Acebutolol—Confusional state—Doxorubicin—ovarian cancer	0.00016	0.000684	CcSEcCtD
Acebutolol—Headache—Docetaxel—ovarian cancer	0.00016	0.00068	CcSEcCtD
Acebutolol—Oedema—Doxorubicin—ovarian cancer	0.000159	0.000678	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000157	0.000668	CcSEcCtD
Acebutolol—Shock—Doxorubicin—ovarian cancer	0.000156	0.000667	CcSEcCtD
Acebutolol—Nervous system disorder—Doxorubicin—ovarian cancer	0.000156	0.000665	CcSEcCtD
Acebutolol—Insomnia—Epirubicin—ovarian cancer	0.000155	0.000663	CcSEcCtD
Acebutolol—Skin disorder—Doxorubicin—ovarian cancer	0.000154	0.000658	CcSEcCtD
Acebutolol—Paraesthesia—Epirubicin—ovarian cancer	0.000154	0.000658	CcSEcCtD
Acebutolol—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000154	0.000655	CcSEcCtD
Acebutolol—Dyspnoea—Epirubicin—ovarian cancer	0.000153	0.000653	CcSEcCtD
Acebutolol—Somnolence—Epirubicin—ovarian cancer	0.000153	0.000651	CcSEcCtD
Acebutolol—Anorexia—Doxorubicin—ovarian cancer	0.000152	0.000646	CcSEcCtD
Acebutolol—Nausea—Docetaxel—ovarian cancer	0.000151	0.000645	CcSEcCtD
Acebutolol—Dyspepsia—Epirubicin—ovarian cancer	0.000151	0.000645	CcSEcCtD
Acebutolol—Decreased appetite—Epirubicin—ovarian cancer	0.000149	0.000637	CcSEcCtD
Acebutolol—Hypotension—Doxorubicin—ovarian cancer	0.000149	0.000633	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000148	0.000633	CcSEcCtD
Acebutolol—Fatigue—Epirubicin—ovarian cancer	0.000148	0.000632	CcSEcCtD
Acebutolol—Constipation—Epirubicin—ovarian cancer	0.000147	0.000627	CcSEcCtD
Acebutolol—Pain—Epirubicin—ovarian cancer	0.000147	0.000627	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000145	0.000618	CcSEcCtD
Acebutolol—Insomnia—Doxorubicin—ovarian cancer	0.000144	0.000613	CcSEcCtD
Acebutolol—Paraesthesia—Doxorubicin—ovarian cancer	0.000143	0.000609	CcSEcCtD
Acebutolol—Dyspnoea—Doxorubicin—ovarian cancer	0.000142	0.000604	CcSEcCtD
Acebutolol—Feeling abnormal—Epirubicin—ovarian cancer	0.000142	0.000604	CcSEcCtD
Acebutolol—Somnolence—Doxorubicin—ovarian cancer	0.000141	0.000603	CcSEcCtD
Acebutolol—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000141	0.000599	CcSEcCtD
Acebutolol—Dyspepsia—Doxorubicin—ovarian cancer	0.00014	0.000597	CcSEcCtD
Acebutolol—Decreased appetite—Doxorubicin—ovarian cancer	0.000138	0.000589	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000137	0.000585	CcSEcCtD
Acebutolol—Fatigue—Doxorubicin—ovarian cancer	0.000137	0.000584	CcSEcCtD
Acebutolol—Urticaria—Epirubicin—ovarian cancer	0.000137	0.000582	CcSEcCtD
Acebutolol—Pain—Doxorubicin—ovarian cancer	0.000136	0.00058	CcSEcCtD
Acebutolol—Constipation—Doxorubicin—ovarian cancer	0.000136	0.00058	CcSEcCtD
Acebutolol—Abdominal pain—Epirubicin—ovarian cancer	0.000136	0.000579	CcSEcCtD
Acebutolol—Body temperature increased—Epirubicin—ovarian cancer	0.000136	0.000579	CcSEcCtD
Acebutolol—Feeling abnormal—Doxorubicin—ovarian cancer	0.000131	0.000559	CcSEcCtD
Acebutolol—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.00013	0.000554	CcSEcCtD
Acebutolol—Urticaria—Doxorubicin—ovarian cancer	0.000126	0.000539	CcSEcCtD
Acebutolol—Abdominal pain—Doxorubicin—ovarian cancer	0.000126	0.000536	CcSEcCtD
Acebutolol—Body temperature increased—Doxorubicin—ovarian cancer	0.000126	0.000536	CcSEcCtD
Acebutolol—Asthenia—Epirubicin—ovarian cancer	0.000123	0.000526	CcSEcCtD
Acebutolol—Pruritus—Epirubicin—ovarian cancer	0.000122	0.000518	CcSEcCtD
Acebutolol—Atenolol—ABCB1—ovarian cancer	0.000121	0.46	CrCbGaD
Acebutolol—Diarrhoea—Epirubicin—ovarian cancer	0.000118	0.000501	CcSEcCtD
Acebutolol—Asthenia—Doxorubicin—ovarian cancer	0.000114	0.000486	CcSEcCtD
Acebutolol—Dizziness—Epirubicin—ovarian cancer	0.000114	0.000485	CcSEcCtD
Acebutolol—Pruritus—Doxorubicin—ovarian cancer	0.000113	0.00048	CcSEcCtD
Acebutolol—Vomiting—Epirubicin—ovarian cancer	0.000109	0.000466	CcSEcCtD
Acebutolol—Diarrhoea—Doxorubicin—ovarian cancer	0.000109	0.000464	CcSEcCtD
Acebutolol—Rash—Epirubicin—ovarian cancer	0.000108	0.000462	CcSEcCtD
Acebutolol—Dermatitis—Epirubicin—ovarian cancer	0.000108	0.000462	CcSEcCtD
Acebutolol—Headache—Epirubicin—ovarian cancer	0.000108	0.000459	CcSEcCtD
Acebutolol—Dizziness—Doxorubicin—ovarian cancer	0.000105	0.000448	CcSEcCtD
Acebutolol—Nausea—Epirubicin—ovarian cancer	0.000102	0.000435	CcSEcCtD
Acebutolol—Vomiting—Doxorubicin—ovarian cancer	0.000101	0.000431	CcSEcCtD
Acebutolol—Rash—Doxorubicin—ovarian cancer	0.0001	0.000427	CcSEcCtD
Acebutolol—Dermatitis—Doxorubicin—ovarian cancer	0.0001	0.000427	CcSEcCtD
Acebutolol—Headache—Doxorubicin—ovarian cancer	9.96e-05	0.000425	CcSEcCtD
Acebutolol—Nausea—Doxorubicin—ovarian cancer	9.45e-05	0.000403	CcSEcCtD
Acebutolol—Metoprolol—ABCB1—ovarian cancer	9.41e-05	0.359	CrCbGaD
Acebutolol—Propranolol—ABCB1—ovarian cancer	4.75e-05	0.181	CrCbGaD
